IL1RL2 and dermatitis: Comprising three agonists (IL-36α, IL-36β, and IL-36γ) and two antagonists (IL-36Ra and IL-38), these cytokines interact with the IL-36 receptor (IL-36R) to activate inflammatory pathways that are essential for the initiation and maintenance of skin inflammation [14,15].